Factors affecting treatment decisions for endoscopically resected low- and high-risk malignant colorectal polyps in a screening setting.

Colorectal cancer Malignant colorectal polyp Mass screening Polypectomy Resection

Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
25 Sep 2024
Historique:
received: 15 04 2024
revised: 22 08 2024
accepted: 30 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 26 9 2024
Statut: aheadofprint

Résumé

The European Guidelines for colorectal cancer screening of 2006 state that only high-risk endoscopically resected malignant colorectal polyps (MCPs), defined as poor/no differentiation or positive resection margins or lymphovascular invasion, require colonic resection. A multicentre series of 954 patients with screen-detected MCP (northern Italy, 2005-2016, age 50-69) was studied to identify (1) the factors affecting the choice of colonic resection, and (2) the factors associated with deviation from the European Guidelines for low- and high-risk patients. Data analysis was based on multilevel logistic regression models. Five hundred sixty-four (59.1 %) patients underwent colonic resection. The factors significantly associated with surgical referral included: distal and rectal versus proximal tumour site (inverse association); sessile and flat versus pedunculated morphology (direct association); tumour size (direct); moderate/poor versus good differentiation (direct); adenocarcinoma of not otherwise specified type versus adenocarcinoma with a residual adenoma component (direct); positive versus negative resection margins (direct); lymphovascular invasion (direct); and high-grade versus low-grade/absent tumour budding (direct). In low-risk MCPs, tumour budding encouraged strongly the decision for surgery. In high-risk MCPs, a distal/rectal tumour site encouraged the follow-up option. The identification of factors associated with treatment choices other than those currently recommended may help prioritise the clinical questions in the development of future guidelines.

Identifiants

pubmed: 39327146
pii: S1590-8658(24)01002-8
doi: 10.1016/j.dld.2024.08.057
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have no conflicts of interest to declare.

Auteurs

Orietta Giuliani (O)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Flavia Baldacchini (F)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Lauro Bucchi (L)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy. Electronic address: lauro.bucchi@irst.emr.it.

Silvia Mancini (S)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Alessandra Ravaioli (A)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Rosa Vattiato (R)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Federica Zamagni (F)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.

Romano Sassatelli (R)

Unit of Gastroenterology and Digestive Endoscopy, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Omero Triossi (O)

Gastroenterology Unit, Local Health Authority, Santa Maria delle Croci Hospital, Ravenna, Italy.

Paolo Trande (P)

Struttura Semplice Dipartimentale Screening del Colon-Retto, AUSL di Modena, Modena, Italy.

Caterina Palmonari (C)

Western Health District and UOSD Management, Epidemiology, Oncologic screening, Health promotion programmes, AUSL Ferrara, Ferrara, Italy.

Alessandro Mussetto (A)

Gastroenterology Unit, Local Health Authority, Santa Maria delle Croci Hospital, Ravenna, Italy.

Carlo Fabbri (C)

Gastroenterology and Digestive Endoscopy Unit, Local Health Authority, Forlì-Cesena, Italy.

Mauro Giovanardi (M)

Gastroenterology and Digestive Endoscopy Unit, Local Health Authority, Rimini, Italy.

Angelo de Padova (A)

Gastroenterology and Digestive Endoscopy Unit, Local Health Authority, Rimini, Italy.

Fabio Falcini (F)

Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy; Cancer Prevention Unit, Local Health Authority, Forlì, Italy.

Classifications MeSH